Strontium-89--precursor targeted therapy for pain relief of blastic metastatic disease. | Cancer;72(11 Suppl): 3433-5, 1993 Dec 01. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Strontium-89--precursor targeted therapy for pain relief of blastic metastatic disease.

Robinson, R G.

Affiliation

Robinson RG; Department of Diagnostic Radiology, University of Kansas Medical Center, Kansas City 66160-7234.

Cancer ; 72(11 Suppl): 3433-5, 1993 Dec 01.

Article in En | MEDLINE | ID: mdl-8242575

Subject(s)

Bone Neoplasms/physiopathology; Bone Neoplasms/secondary; Pain/radiotherapy; Strontium Radioisotopes/therapeutic use; Humans; Osteoblasts/radiation effects; Strontium Radioisotopes/administration & dosage; Strontium Radioisotopes/adverse effects; Strontium Radioisotopes/pharmacology

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pain / Strontium Radioisotopes / Bone Neoplasms Limits: Humans Language: En Journal: Cancer Year: 1993 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Pain / Strontium Radioisotopes / Bone Neoplasms Limits: Humans Language: En Journal: Cancer Year: 1993 Document type: Article Country of publication: United States